| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,855 |
4,964 |
$190K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
2,713 |
1,996 |
$95K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
809 |
598 |
$9K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
281 |
207 |
$5K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
77 |
67 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
1,905 |
1,499 |
$2K |
| 90688 |
|
273 |
202 |
$2K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
114 |
83 |
$2K |
| 92552 |
|
149 |
110 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
73 |
44 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
235 |
175 |
$2K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
21 |
16 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
79 |
59 |
$1K |
| 90756 |
|
51 |
42 |
$769.46 |
| 99408 |
|
49 |
31 |
$551.56 |
| 99173 |
|
143 |
100 |
$333.87 |
| 90686 |
|
59 |
52 |
$244.08 |
| 90658 |
|
25 |
16 |
$226.84 |
| 96127 |
|
49 |
31 |
$169.69 |
| 3008F |
|
74 |
60 |
$110.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
15 |
12 |
$105.45 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
279 |
215 |
$86.97 |
| 81003 |
|
108 |
84 |
$86.08 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
80 |
57 |
$85.17 |